|
|
 |
|
Viewing report
|
|
|
|
Therapeutic Strategies in Acute Exacerbations in COPD
Clinical Publishing, June 2009, Pages: 224
The pronounced variability in the incidence and severity of chronic respiratory diseases such as asthma and COPD, makes effective treatment more difficult, and the social and economic costs of these diseases all the greater. Acute exacerbations are multi-factorial in origin, and are known to be linked with a number of agents including allergens, atmospheric pollution and infectious agents. Effective treatment requires a similarly complex approach that addresses each of the component causes. This text brings together current knowledge of the epidemiology and pathophysiology of these episodes, and the latest experimental models by which researchers are seeking to improve our understanding of their incidence and progression. The book concludes with a review of the latest ideas on therapy for exacerbations. The authors evaluate the individual efficacy of current treatments in the light of this knowledge and present new recommendations for formulating effective therapeutic regimes.
Benefits:
- First available text on management of acute COPD
- Presents a comprehensive review of current treatment options
- Evidence-based solutions provided by experts in the field
Readership:
- Specialists in respiratory medicine
- General physicians
- Doctors in training
- Hospital pharmacists
Product samples
A sample for this product is available. Please Login/Register to download this sample.
Customers who bought this item also bought
Chronic Obstructive Pulmonary Disease (COPD): KOL Insights on Treatment Practices and Unmet Needs
Respiratory Therapeutics and Devices Markets
Bronchitis Therapeutics - Pipeline Assessment and Market Forecasts to 2018
Respiratory Disorders Therapeutics Market to 2017 - Novel Pipeline Molecules such as VX-770 and pirfenidone May Offset Negative Effect of Patent Expiries
Treating COPD Comorbidities: A Market Opportunity for Systemic Anti-Inflammatory Agents?
Chronic Obstructive Pulmonary Disease - Global Strategic Business Report
Chronic Obstructive Pulmonary Disease (COPD) Therapeutics - Pipeline Assessment and Market Forecasts to 2018
Biomarker and Diagnostic Opportunities in Respiratory Diseases
The Future of Respiratory Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis
Chronic Obstructive Pulmonary Disease (COPD) Global Clinical Trials Review, H2, 2011
|
|
|
|
